Home/Events/Science Corporation Raises $400 Million Series D, Valued at $3.5 Billion

Science Corporation Raises $400 Million Series D, Valued at $3.5 Billion

Confirmed
Confidence
90%
Impact: 80%
Updated 1d ago

Consensus Brief

Science Corporation, founded by former Neuralink president Max Hodak, has raised $400 million in a Series D funding round, bringing its valuation to $3.5 billion. The company aims to leverage its technology to understand and interact with the brain, with its first product, PRIMA, already approved in Europe for treating age-related macular degeneration.

Sourced from
Primary: TechCrunch

What Changed Since Last Update

1d ago

New corroborating source added: TechCrunch published an update on Tue, 17 No ("Science Corporation’s brain tech is worth $3.5 billion after new funding").

Claim Ledger

5 claims tracked across sources

Confirmed Fact

Science Corporation raised a $400 million Series D.

Confirmed Fact

The company is valued at $3.5 billion.

Confirmed Fact

PRIMA is approved in Europe and available in Germany.

Official Claim

The device is being trialled for Stargardt’s disease.

Official Claim

The company aims to bring the device to the United States through the FDA’s Humanitarian Device Exemption.

Role-Based Impact Analysis